bioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Decrease in Short Interest

bioMérieux S.A. (OTCMKTS:BMXMF) was the target of a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 118,300 shares, a decline of 19.1% from the December 15th total of 146,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 1,183.0 days.

bioMérieux Price Performance

BMXMF opened at $116.49 on Friday. bioMérieux has a 1 year low of $93.50 and a 1 year high of $122.52. The firm has a 50 day moving average price of $105.37 and a 200 day moving average price of $108.85.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.